Difficulty: Medium
Average Score: 83%
Practice
Which one of the following is a cardio selective $ß1$-blocker:
Correct answer
B
Rationale
In the context of drugs for the peripheral nervous system, understanding the selectivity of beta-blockers is crucial for clinical practice. Metoprolol, option B, is the correct answer as it is a cardioselective beta-1 blocker. The rationale behind this is that metoprolol primarily targets beta-1 receptors in the heart, leading to a decrease in heart rate and contractility without significantly affecting beta-2 receptors in the lungs.
Option A, Timolol, is a non-selective beta-blocker affecting both beta-1 and beta-2 receptors, leading to potential bronchoconstriction in patients with respiratory issues. Option C, Nadolol, is also a non-selective beta-blocker, impacting both beta-1 and beta-2 receptors and potentially causing similar pulmonary issues.
Option D, Sotalol, is not a beta-blocker but rather a non-selective beta-adrenergic antagonist with Class III antiarrhythmic properties, primarily used for treating atrial and ventricular arrhythmias, making it an incorrect choice for a cardioselective beta-1 blocker.
Educationally, knowing the selectivity of beta-blockers is vital for prescribing appropriate medications for patients with specific conditions. Understanding the variations in selectivity can help prevent adverse effects and optimize treatment outcomes, showcasing the importance of pharmacological knowledge in clinical decision-making.
Option A, Timolol, is a non-selective beta-blocker affecting both beta-1 and beta-2 receptors, leading to potential bronchoconstriction in patients with respiratory issues. Option C, Nadolol, is also a non-selective beta-blocker, impacting both beta-1 and beta-2 receptors and potentially causing similar pulmonary issues.
Option D, Sotalol, is not a beta-blocker but rather a non-selective beta-adrenergic antagonist with Class III antiarrhythmic properties, primarily used for treating atrial and ventricular arrhythmias, making it an incorrect choice for a cardioselective beta-1 blocker.
Educationally, knowing the selectivity of beta-blockers is vital for prescribing appropriate medications for patients with specific conditions. Understanding the variations in selectivity can help prevent adverse effects and optimize treatment outcomes, showcasing the importance of pharmacological knowledge in clinical decision-making.